What should be the protocol selection after failure of in-vitro fertilization at normoresponder patients: Agonist or antagonist?
Open Access
- 5 December 2014
- journal article
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 11 (4) , 198-202
Abstract
Evaluation of the impact of agonist or antagonist protocol selection on pregnancy outcomes after failure of in-vitro fertilization (IVF) treatment cycles which were down regulated with Gonadotropin Releasing Hormone (GnRH) agonist. This was a retrospective study. Two hundred and sixty nine patients who were treated with GnRH agonist protocol between years 2002-2012 at an IVF unit and underwent a second attempt following one year period after failure of IVF enrolled in the study. Age, basal FSH levels, antral follicle counts, duration of induction, the number of yielded oocytes, the number of transferred embryos and the transfer days, clinical and ongoing pregnancy rates were evaluated for each treatment cycle. Normoresponder patients were separated into two groups according to the agonist or antagonist protocol selection at the second attempt and the results of two consequent IVF cycles were compared. There were no statistically significant difference between the groups for the dosage of administered gonadotropin, duration of induction, the count of yielded oocytes, the day and the number of transferred embryos (p>0.05). Furthermore the fertilization rate, clinical and ongoing pregnancy rates were similar in two groups. The selection of antagonist treatment is effective as agonist protocols at normoresponder patients after failure of IVF.Keywords
This publication has 20 references indexed in Scilit:
- GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET)Reproductive Biology and Endocrinology, 2012
- Gonadotrophin-releasing hormone antagonists for assisted reproductive technology2011
- Comparison of GnRH agonists and antagonists in normoresponder IVF/ICSI in Turkish female patientsAdvances in Therapy, 2008
- GnRH antagonists in IVFReproductive BioMedicine Online, 2005
- GnRH-antagonists in reproductive medicineArchives of Gynecology and Obstetrics, 2005
- Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow?Fertility and Sterility, 2005
- To agonize or antagonize in gonadotrophin stimulation cycles?Reproductive BioMedicine Online, 2005
- Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocolArchives of Gynecology and Obstetrics, 2001
- Gonadotrophin-releasing hormone antagonists for assisted conception2001
- Preserved pituitary response under ovarian stimulation with HMG and GnRH antagonists (Cetrorelix) in women with tubal infertilityEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1995